Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-032202
Filing Date
2025-03-04
Accepted
2025-03-04 16:36:07
Documents
1
Period of Report
2025-02-26

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 1705
  Complete submission text file 0000950170-25-032202.txt   3465
Mailing Address 22 EINSTEIN ST. FLOOR 4 NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST. FLOOR 4 NESS ZIONA L3 7414003 972 723942377
BiomX Inc. (Issuer) CIK: 0001739174 (see all company filings)

EIN.: 823364020 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 4550 MONTGOMERY STREET SUITE 1100N BETHESDA MD 20814
Business Address 4550 MONTGOMERY STREET SUITE 1100N BETHESDA MD 20814 301-951-4422
Cystic Fibrosis Foundation (Reporting) CIK: 0001957515 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38762 | Film No.: 25705322